Status:
UNKNOWN
The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination
Lead Sponsor:
Beijing Center for Disease Control and Prevention
Conditions:
Varicella
Eligibility:
All Genders
4-12 years
Phase:
PHASE4
Brief Summary
To investigate the safety, immunogenicity and immune effect of the Varicella vaccine after the 2nd dose vaccination in Chao yang district, Bei jing, since the 2nd varicella vaccination was promoted by...
Detailed Description
"Breakthrough" varicella cases and varicella cases were monitored to evaluate the protective effective in a large population. Make the basic evaluation of safety for the two dose of varicella vaccina...
Eligibility Criteria
Inclusion
- Participants were between 4-12 years old
- Participants were in good healthy determined through medical history, physical examination, clinical judgment of the investor
Exclusion
- Having a fever (axillary temperature \>37.0℃) before enrollment;
- Having a disease history of seizures, brain and mental disease and the vaccination history of allergies and convulsions;
- Antibiotics allergy;
- Having a problem of intramuscular injection because thrombocytopenia or other blood coagulation disorder;
- Having immunodeficiency or under immunosuppression therapy, radiation therapy;
- Having respiratory diseases, acute infection, chronic disease and HIV infection;
- Having systemic skin rash, skin tinea, herpes;
- Chronic liver and kidney disease;
- Heart disease, and severe hypertension;
- Have received whole blood, plasma or immunoglobulin therapy 3 months before enrollment;
- Have not received other vaccination in 7 days before enrollment
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2018
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT01830283
Start Date
April 1 2013
End Date
April 1 2018
Last Update
May 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Chaoyang District Centers for Disease Control and Prevention
Beijing, China